# DMD

## Overview
The DMD gene is responsible for encoding the dystrophin protein, a crucial cytoskeletal protein that plays a significant role in maintaining the structural integrity of muscle cells. Dystrophin is a large protein, categorized as a cytoskeletal protein, and is a key component of the dystrophin-associated protein complex (DAPC), which links the intracellular cytoskeleton to the extracellular matrix. This connection is vital for protecting muscle fibers from damage during contraction and relaxation cycles. The gene is located on the X chromosome, and mutations in DMD can lead to severe muscular dystrophies, such as Duchenne Muscular Dystrophy (DMD) and Becker Muscular Dystrophy (BMD), characterized by progressive muscle degeneration and weakness (Duan2021Duchenne). Beyond its role in muscle tissue, dystrophin is also expressed in the brain, where it is involved in cognitive functions, and mutations can have neuropsychiatric implications (Ricotti2015Neurodevelopmental; Duan2021Duchenne).

## Structure
The DMD gene encodes the dystrophin protein, a large cytoskeletal protein crucial for muscle fiber integrity. Dystrophin has a molecular weight of 427 kDa and consists of 3685 amino acid residues (Nicolas2012Assessment; Duan2021Duchenne). Its primary structure includes four main domains: the N-terminal actin-binding domain (ABD), the central rod domain, the cysteine-rich domain, and the C-terminal domain (Nicolas2012Assessment; Muntoni2003Dystrophin).

The N-terminal ABD comprises the first 246 residues and binds to F-actin (Nicolas2012Assessment; Ehmsen2002The). The central rod domain, spanning residues 247 to 3045, is composed of 24 spectrin-like repeats and four hinges, contributing to its flexible rod-like structure (Nicolas2012Assessment; Duan2021Duchenne). The cysteine-rich domain, from residues 3080 to 3360, interacts with β-dystroglycan, while the C-terminal domain binds to dystrobrevin and syntrophins (Nicolas2012Assessment).

Dystrophin undergoes post-translational modifications, including phosphorylation, which affects its interactions with F-actin and syntrophin (Muntoni2003Dystrophin). The protein forms part of the dystrophin-glycoprotein complex, linking the cytoskeleton to the extracellular matrix, essential for muscle integrity (Ehmsen2002The). Multiple isoforms of dystrophin are produced through alternative splicing, including Dp427m, Dp260, Dp140, Dp116, and Dp71, each with distinct tissue-specific functions (Duan2021Duchenne; Muntoni2003Dystrophin).

## Function
The DMD gene encodes the dystrophin protein, which is crucial for maintaining the structural integrity of muscle cells. Dystrophin is a key component of the dystrophin-associated protein complex (DAPC), which connects the cytoskeleton of muscle fibers to the extracellular matrix through the cell membrane. This connection is vital for protecting muscle fibers from damage during contraction and relaxation cycles (Duan2021Duchenne). 

Dystrophin interacts with various proteins, including actin microfilaments, intermediate filaments, and microtubules, as well as channel proteins and signaling or scaffolding proteins. These interactions help maintain the mechanical stability and signaling functions of muscle cells (Duan2021Duchenne). Dystrophin also anchors neuronal nitric oxide synthase (nNOS) to the sarcolemma, facilitating the production and release of nitric oxide, which leads to vasodilation and ensures adequate blood perfusion in contracting muscles (Duan2021Duchenne).

In addition to its role in muscle tissue, dystrophin is expressed in other tissues, including the brain, where it is involved in cognitive functions. In the brain, dystrophin is expressed in postsynaptic inhibitory GABAergic neurons and is associated with cognitive functions (Duan2021Duchenne).

## Clinical Significance
Mutations in the DMD gene, which encodes the dystrophin protein, lead to several muscular dystrophies, primarily Duchenne Muscular Dystrophy (DMD) and Becker Muscular Dystrophy (BMD). DMD is a severe, X-linked disorder characterized by progressive muscle degeneration and weakness, typically manifesting in early childhood. It is caused by out-of-frame mutations that result in the absence of functional dystrophin, leading to muscle fiber damage and replacement by fibrotic and fatty tissue (Bladen2015The; Duan2021Duchenne). BMD, a milder form, results from in-frame mutations that allow for some dystrophin production, albeit in reduced amounts or altered forms (Bladen2015The).

The absence or dysfunction of dystrophin disrupts the dystrophin-associated protein complex (DAPC), compromising muscle cell membrane stability and repair, and leading to increased susceptibility to mechanical stress and calcium dysregulation (Nakamura2019MutationBased; Duan2021Duchenne). This cascade of events contributes to muscle degeneration, chronic inflammation, and impaired muscle regeneration (Duan2021Duchenne).

Mutations in the DMD gene also have neuropsychiatric implications. Individuals with DMD often exhibit intellectual disabilities, autism spectrum disorders, and attention-deficit/hyperactivity disorder, particularly when mutations affect brain-specific dystrophin isoforms (Ricotti2015Neurodevelopmental). These findings suggest a potential 'DMD neuropsychiatric syndrome' that may require early intervention (Ricotti2015Neurodevelopmental).

## Interactions
Dystrophin, encoded by the DMD gene, is a key component of the dystrophin-associated protein complex (DAPC), which plays a crucial role in linking the intracellular cytoskeleton to the extracellular matrix in muscle cells. This complex includes several proteins such as dystroglycans, sarcoglycans, sarcospan, syntrophins, and dystrobrevin (Ehmsen2002The; Barresi2011From; Duan2021Duchenne). Dystrophin interacts with actin filaments through its N-terminal actin-binding domain and binds to β-dystroglycan via its C-terminal cysteine-rich domain, forming a transmembrane link that connects the cytoskeleton to extracellular matrix proteins like laminin-2 (Ehmsen2002The; Barresi2011From).

Dystrophin also associates with neuronal nitric oxide synthase (nNOS), which is anchored to the sarcolemma, facilitating nitric oxide production for vasodilation during muscle contraction (Duan2021Duchenne). The protein interacts with other components of the DAPC, such as α-syntrophin, which recruits additional proteins to the complex, including plasma membrane calcium ATPase and various channel proteins (Duan2021Duchenne). These interactions are essential for maintaining muscle integrity and function, and disruptions can lead to muscular dystrophies (Ehmsen2002The).


## References


[1. (Bladen2015The) Catherine L. Bladen, David Salgado, Soledad Monges, Maria E. Foncuberta, Kyriaki Kekou, Konstantina Kosma, Hugh Dawkins, Leanne Lamont, Anna J. Roy, Teodora Chamova, Velina Guergueltcheva, Sophelia Chan, Lawrence Korngut, Craig Campbell, Yi Dai, Jen Wang, Nina Barišić, Petr Brabec, Jaana Lahdetie, Maggie C. Walter, Olivia Schreiber-Katz, Veronika Karcagi, Marta Garami, Venkatarman Viswanathan, Farhad Bayat, Filippo Buccella, En Kimura, Zaïda Koeks, Janneke C. van den Bergen, Miriam Rodrigues, Richard Roxburgh, Anna Lusakowska, Anna Kostera-Pruszczyk, Janusz Zimowski, Rosário Santos, Elena Neagu, Svetlana Artemieva, Vedrana Milic Rasic, Dina Vojinovic, Manuel Posada, Clemens Bloetzer, Pierre-Yves Jeannet, Franziska Joncourt, Jordi Díaz-Manera, Eduard Gallardo, A. Ayşe Karaduman, Haluk Topaloğlu, Rasha El Sherif, Angela Stringer, Andriy V. Shatillo, Ann S. Martin, Holly L. Peay, Matthew I. Bellgard, Jan Kirschner, Kevin M. Flanigan, Volker Straub, Kate Bushby, Jan Verschuuren, Annemieke Aartsma-Rus, Christophe Béroud, and Hanns Lochmüller. The treat-nmd dmd global database: analysis of more than 7,000 duchenne muscular dystrophy mutations. Human Mutation, 36(4):395–402, March 2015. URL: http://dx.doi.org/10.1002/humu.22758, doi:10.1002/humu.22758. This article has 715 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1002/humu.22758)

[2. (Ehmsen2002The) Jeffrey Ehmsen, Ellen Poon, and Kay Davies. The dystrophin-associated protein complex. Journal of Cell Science, 115(14):2801–2803, July 2002. URL: http://dx.doi.org/10.1242/jcs.115.14.2801, doi:10.1242/jcs.115.14.2801. This article has 115 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1242/jcs.115.14.2801)

[3. (Barresi2011From) Rita Barresi. From proteins to genes: immunoanalysis in the diagnosis of muscular dystrophies. Skeletal Muscle, 1(1):24, 2011. URL: http://dx.doi.org/10.1186/2044-5040-1-24, doi:10.1186/2044-5040-1-24. This article has 38 citations and is from a peer-reviewed journal.](https://doi.org/10.1186/2044-5040-1-24)

[4. (Ricotti2015Neurodevelopmental) Valeria Ricotti, William P L Mandy, Mariacristina Scoto, Marika Pane, Nicolas Deconinck, Sonia Messina, Eugenio Mercuri, David H Skuse, and Francesco Muntoni. Neurodevelopmental, emotional, and behavioural problems in duchenne muscular dystrophy in relation to underlying dystrophin gene mutations. Developmental Medicine &amp; Child Neurology, 58(1):77–84, September 2015. URL: http://dx.doi.org/10.1111/dmcn.12922, doi:10.1111/dmcn.12922. This article has 214 citations.](https://doi.org/10.1111/dmcn.12922)

[5. (Nakamura2019MutationBased) Akinori Nakamura. Mutation-based therapeutic strategies for duchenne muscular dystrophy: from genetic diagnosis to therapy. Journal of Personalized Medicine, 9(1):16, March 2019. URL: http://dx.doi.org/10.3390/jpm9010016, doi:10.3390/jpm9010016. This article has 29 citations and is from a peer-reviewed journal.](https://doi.org/10.3390/jpm9010016)

[6. (Nicolas2012Assessment) Aurélie Nicolas, Céline Lucchetti-Miganeh, Rabah Ben Yaou, Jean-Claude Kaplan, Jamel Chelly, France Leturcq, Frédérique Barloy-Hubler, and Elisabeth Le Rumeur. Assessment of the structural and functional impact of in-frame mutations of the dmd gene, using the tools included in the edystrophin online database. Orphanet Journal of Rare Diseases, July 2012. URL: http://dx.doi.org/10.1186/1750-1172-7-45, doi:10.1186/1750-1172-7-45. This article has 47 citations and is from a peer-reviewed journal.](https://doi.org/10.1186/1750-1172-7-45)

[7. (Muntoni2003Dystrophin) Francesco Muntoni, Silvia Torelli, and Alessandra Ferlini. Dystrophin and mutations: one gene, several proteins, multiple phenotypes. The Lancet Neurology, 2(12):731–740, December 2003. URL: http://dx.doi.org/10.1016/s1474-4422(03)00585-4, doi:10.1016/s1474-4422(03)00585-4. This article has 803 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1016/s1474-4422(03)00585-4)

[8. (Duan2021Duchenne) Dongsheng Duan, Nathalie Goemans, Shin’ichi Takeda, Eugenio Mercuri, and Annemieke Aartsma-Rus. Duchenne muscular dystrophy. Nature Reviews Disease Primers, February 2021. URL: http://dx.doi.org/10.1038/s41572-021-00248-3, doi:10.1038/s41572-021-00248-3. This article has 578 citations.](https://doi.org/10.1038/s41572-021-00248-3)